Tokyo Theatres Company, Incorporated
Notice of Revision to Earnings Guidance
Revised the full-year consolidated earnings guidance for the fiscal year ending March 2027. Net sales upwardly revised to 21,000 hundred million yen, operating income to 400 million yen, ordinary income to 450 million yen, net income attributable to owners of parent to 2,800 million yen, and earnings per share to 413.27 yen. Compared with the previous forecast, net sales increased by 1,200 million yen and all profit items were raised. The revision reason is that the impact on procurement of construction materials for the resale renovation business for used condominiums was limited, and results through the first half exceeded expectations. No change to the dividend forecast at this time.
Key Figures
- Net Sales: 21,000 hundred million yen
- Operating Income: 400 million yen
- Ordinary Income: 450 million yen
- Net Income Attributable to Owners of Parent: 2,800 million yen
AI要約
Summary of Revision to Earnings Guidance
Tokyo Theatres Company, Incorporated has upwardly revised its full-year consolidated earnings guidance for the fiscal year ending March 2027. Net sales have been revised up from 19,800 hundred million yen to 21,000 hundred million yen; operating income from 300 million yen to 400 million yen; ordinary income from 350 million yen to 450 million yen; and net income attributable to owners of parent from 2,700 million yen to 2,800 million yen. Earnings per share have also been raised from 394.63 yen to 413.27 yen.
Background and Outlook
The reason for the revision is that the impact of difficulties in procuring construction materials, stemming from Middle East conditions, on the resale renovation business for used condominiums was limited, and first-half results exceeded expectations, prompting an upward revision to the full-year forecast. No change to the dividend forecast has been announced at this time. Future figures may fluctuate depending on market trends and movements in material costs.
Tokyo Theatres Company, Incorporated
Company overview · Stock price · Financial data · All IR
